ADP
65
-3
SRE
63
2
MMM
35
-5
AMAT
33
-13
COF
62
3
WU
24
4
INTC
41
4
CVX
43
-3
GT
56
-3
DTE
43
5
WMT
56
-4
KEY
43
-3
NEM
40
3
MDLZ
32
-4
ICE
59
-3
ZTS
47
2
NOV
52
-5
MCO
71
-7
BXP
49
-3
USB
50
-3
ADP
65
-3
SRE
63
2
MMM
35
-5
AMAT
33
-13
COF
62
3
WU
24
4
INTC
41
4
CVX
43
-3
GT
56
-3
DTE
43
5
WMT
56
-4
KEY
43
-3
NEM
40
3
MDLZ
32
-4
ICE
59
-3
ZTS
47
2
NOV
52
-5
MCO
71
-7
BXP
49
-3
USB
50
-3
Financhill
Back

Repligen Stock Predictions

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.
Sell
30

RGEN
Repligen

Last Price:
124.90
Seasonality Move:
7.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.

Repligen Stock Forecast

  • Over the next 52 weeks, Repligen has on average historically risen by 22% based on the past 38 years of stock performance.
  • Repligen has risen higher in 21 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.26%
  • Is Repligen Stock Undervalued?
    The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Repligen Stock Go Up Next Year?

  • Over the next 52 weeks, Repligen has on average historically risen by 22% based on the past 38 years of stock performance.

Repligen Stock Rating

Sell
30
Repligen (RGEN) is a Sell

Is Repligen overpriced?

  • Repligen has risen higher in 21 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.26%

Repligen Stock Price History

Is RGEN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com

52-Week Data

52-Week High:
211.13
52-Week Low:
113.50

Prediction Charts

Market Cap:
6.99B
Price in USD:
124.73
Volume:
1.91M
Beta:
0.97

Technical Analysis

SMA50:
141.19
SMA100:
141.82
SMA200:
157.58
52-Wk Change:
-20.01%

Stock Predictions

  • Is Repligen stock public?
    Yes, Repligen is a publicly traded company.
  • What is the Repligen stock quote today?
    The Repligen stock price is 124.73 USD today.
  • How to buy Repligen stock online?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-29 135.89 134.90 138.96 133.58
Oct-30 133.56 136.41 139.25 133.56
Oct-31 135.08 134.24 137.50 134.12
Nov-1 134.27 138.61 138.79 134.27
Nov-4 138.64 139.67 140.74 136.41
Nov-5 138.32 145.95 146.03 138.32
Nov-6 150.10 145.93 150.78 141.00
Nov-7 145.26 143.88 146.35 142.95
Nov-8 143.04 140.64 143.27 140.00
Nov-11 140.80 139.51 141.83 137.27
Nov-12 147.50 148.59 154.48 145.00
Nov-13 144.96 150.43 154.32 143.95
Nov-14 148.58 142.43 149.88 142.08
Nov-15 140.87 124.73 141.17 121.52

Repligen Earnings

Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.

Repligen Forecast Revenue Growth

Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.